HCW Biologics Inc. (HCWB)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-14) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-31) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-14) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-14) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-15) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-28) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-14) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-14) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-15) · 99.1 | ||
| 10-K/A | FY-2023 | |||
| 10-K | FY-2023 | 8-K (2024-04-01) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-14) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-11) · 99.1 | ||
| 10-Q/A | Q1-2023 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | — |
|
| Document and Entity Information | — |
|
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Statements of Operations | ||
| Statement of Changes In Stockholders' Equity | ||
| Statements of Changes In Stockholders' Equity (deficit) | ||
| Statements of Changes In Stockholders' Equity (deficit) (P) | ||
| Statement of Cash Flows | ||
| Notes | ||
| Accrued Liabilities and Other Current Liabilities | ||
| Collaborative Arrangements | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Debt | ||
| Debt, Net | ||
| Employee Benefit Plan | — |
|
| Fair Value of Financial Instruments | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Investments | — |
|
| License Agreements | ||
| Net Income (loss) Per Share | — |
|
| Net Loss Per Share | ||
| Organization and Summary of Significant Accounting Policies | ||
| Pay Vs Performance Disclosure | ||
| Preferred Stock | ||
| Property and Equipment, Net | — |
|
| Related Party Transactions | — |
|
| Sale of Common Stock and Warrants | ||
| Segment Reporting | ||
| Standby Equity Purchase Agreement | ||
| Stock-based Compensation | — |
|
| Subsequent Events | ||